Effectiveness of DIMS Spectacle as a Function of the Age
Effectiveness of Defocus Incorporated Multiple Segments in Slowing Myopia Progression as a Function of the Age in Pediatric Patients. Three Years Follow up.
1 other identifier
observational
80
1 country
1
Brief Summary
Purpose: To evaluate the effectiveness of Defocus Incorporated Multiple Segments (DIMS) in slowing myopia progression as a function of age in pediatric patients. Methods: This was a non-randomized experimenter-masked retrospective controlled observational study of European individuals aged 6 -16 years with progressive myopia but no ocular pathology. The charts of the participants allocated to receive DIMS spectacles (Hoya® MiyoSmart®) or single vision spectacle lenses (control group) were retrospectively reviewed. The key outcome variables, cycloplegic spherical equivalent (SE) and axial length (AL), were measured at baseline and at 36 month follow up. The results were stratified by age into four groups: patients that wore DIMS spectacles oldest or youngest than 10 years (respectively, group A, 20 patients mean age 13.6±2.2 and group C, 20 patients mean age 9.0±1.2) and age matched control groups (group B, 18 patients mean age 13.2±2.5 and group D, mean age 8.5±0.9).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Dec 2020
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2024
CompletedFirst Submitted
Initial submission to the registry
July 19, 2024
CompletedFirst Posted
Study publicly available on registry
August 16, 2024
CompletedAugust 20, 2024
August 1, 2024
Same day
July 19, 2024
August 19, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
SE
spherical equivalent
36 months
Secondary Outcomes (1)
AL
36 months
Study Arms (4)
Group A: patients oldest than 10 years that wear DIMS lens
myopic patients oldest than 10 years of age that wore Defocus Incorporated Multiple Segments (DIMS) spectacles
Group B: patients oldest than 10 years that wear (control group)
myopic patients oldest than 10 years of age that wore single vision spectacle lenses (control group)
Group C: patients youngest than 10 years that wear DIMS lens
myopic patients youngest than 10 years of age that wore Defocus Incorporated Multiple Segments (DIMS) spectacles
Group D: patients youngest than 10 years (control group)
myopic patients youngest than 10 years of age that wore single vision spectacle lenses (control group)
Interventions
To evaluate the effectiveness of Defocus Incorporated Multiple Segments (DIMS) in slowing myopia progression as a function of age in pediatric patients.
Eligibility Criteria
pediatric patients with documented progressive myopiua
You may qualify if:
- patient age between 6-16 years
- progressive myopia with cycloplegic spherical equivalent (SE) from -0.50 to -4.00 diopters (D)
- astigmatism less than 2.50D, anisometropia under 1.25D
You may not qualify if:
- genetic syndromes suspected (e.g., Stickler, Marfan, etc.)
- systemic diseases
- eye diseases (such as glaucoma, juvenile cataracts, retinal abnormalities, any form of strabismus)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Luca Buzzonettilead
Study Sites (1)
Luca Buzzonetti
Rome, Italy
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Luca Buzzonetti
Bambino Gesù IRCCS Children's Hospital
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Head of Ophthalmology Unit
Study Record Dates
First Submitted
July 19, 2024
First Posted
August 16, 2024
Study Start
December 1, 2020
Primary Completion
December 1, 2020
Study Completion
June 30, 2024
Last Updated
August 20, 2024
Record last verified: 2024-08